The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement

Author

  • Valentina Gallo
  • Matthias Egger
  • Valerie McCormack
  • Peter B. Farmer
  • John P. A. Loannidis
  • Micheline Kirsch-Volders
  • Giuseppe Matullo
  • David H. Phillips
  • Bernadette Schoket
  • Ulf Strömberg
  • Roel Vermeulen
  • Christopher Wild
  • Miguel Porta
  • Paolo Vineis

Summary, in English

Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating the interactions between external and/or endogenous agent.; and the body components or processes. The need for improved reporting of scientific research led to influential statements of recommendations such as the STrenghtening Reporting of Observational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in epidemiological studies, with items specific to the three main study designs: cohort studies, case-control studies and cross-sectional studies. The present STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME) initiative builds on the STROBE Statement implementing 9 existing items of STROBE and providing 17 additional items to the 22 items of STROBE checklist. The additions relate to the use of biomarkers in epidemiological studies, concerning collection, handling and storage of biological samples; laboratory methods. validity and reliability of biomarkers; specificities of study design; and ethical considerations. The STROBE-ME recommendations are intended to complement the STROBE recommendations. (C) 2011 V. Gallo. Published by Elsevier Inc. All rights reserved.

Publishing year

2011

Language

English

Pages

377-387

Publication/Series

Preventive Medicine

Volume

53

Issue

6

Document type

Journal article

Publisher

Elsevier

Topic

  • Public Health, Global Health, Social Medicine and Epidemiology

Keywords

  • Epidemiology
  • Molecular epidemiology
  • Biomarkers
  • Validation
  • Reporting
  • recommendations

Status

Published

ISBN/ISSN/Other

  • ISSN: 1096-0260